Publicaciones científicas

/cun/investigacion/publicaciones-cientificas/areaMain/02
  • CT screening for lung cancer: comparison of three baseline screening protocols

    Henschke CI (1,2,3), Yip R (4), Ma T (4,5), Aguayo SM (6), Zulueta J (7), Yankelevitz DF (4); Writing Committee for the I-ELCAP Investigators.

    (1) Icahn School of Medicine at Mount Sinai, New York, NY, USA. Claudia.
    (2) Phoenix Veterans Affairs Health Care System, Phoenix, AZ, USA. Claudia.
    (3) Department of Radiology, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY, 10029, USA. Claudia.
    (4) Icahn School of Medicine at Mount Sinai, New York, NY, USA.
    (5) Department of Diagnostic Ultrasound, Tong Ren Hospital, Capital Medical University, Beijing, 100730, China.
    (6) Phoenix Veterans Affairs Health Care System, Phoenix, AZ, USA.
    (7) Clinica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Navarra, Spain.

    European Radiology 03 de DICIEMBRE de 2018

  • Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma

    Usmani SZ (1), Hoering A (2), Cavo M (3), Miguel JS (4), Goldschimdt H (5), Hajek R (6), Turesson I (7), Lahuerta JJ (8), Attal M (9), Barlogie B (10), Lee JH (11), Kumar S (12), Lenhoff S (13), Morgan G (14), Rajkumar SV (15), Durie BGM (16), Moreau P (17).

    (1) Hematogic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, United States.
    ()2 Cancer Research and Biostatistics, Seattle, Washington, United States.
    (3) Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
    (4) Centro de Investigación Médica Aplicada, IDISNA, CIBERONC, Clinica Universidad de Navarra, Pamplona, Spain.
    (5) Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
    (6) University Hospital Ostrava and the Faculty of Medicine, CRAB, University of Ostrava Adam Rosenthal, Seattle, United States.
    (7) Department of Hematology, Malmo University Hospital, Malmo, Sweden.
    (8) Hospital Universitario 12 de Octubre, Madrid, Spain.
    (9) Service d'Hématologie, CHU de Toulouse-Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
    (10) Hematology, Mount Sinai University, New York, United States.
    (11) Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
    (12) Department of Internal Medicine, Division of Hematology, Mayo clinic, Rochester, MN, United States.
    (13) Skane University Hospital, Lund, Sweden.
    (14) MIRT, UAMS, Myeloma Insitute, Little Rock, United States.
    (15) Division of Hematology, Mayo Clinic, Rochester, MN, United States.
    (16) Hematology/Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, United States.
    (17) Service d'Hematologie, CHU de Nantes, Nantes, France.

    Blood Cancer Journal 23 de NOVIEMBRE de 2018

  • Comparison of correlations of equation-derived body fat percentage and body mass index with carotid intima-media thickness

    Landecho MF (1,2), Colina I (1,2), Sunsundegui P (1), Camarero B (3), Núñez-Córdoba JM (4,5), Beloqui Ó (1,2).

    (1) General Health Check-up Unit, Internal Medicine Department, Clínica Universidad de Navarra, Avenida Pío XII, 31008, Pamplona, Spain.
    (2) IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
    (3) General Surgery and Digestive System Service, Complejo Hospitalario de Navarra, Pamplona, Spain.
    (4) IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
    (5) Research Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Avenida Pío XII, 36, 31008, Pamplona, Spain.

    Acta Diabetológica 23 de NOVIEMBRE de 2018

  • Can we treat systemic lupus erythematosus and other autoimmune diseases without oral steroids?

    Enriquez Merayo E (1), Sciascia S (2,3), Roccatello D (2,3), Cuadrado MJ (1).

    (1a) Rheumatology Department , Clinica Universidad de Navarra , Madrid , Spain.
    (2b) Center of Research of Immunopathology and Rare Diseases- Coordinating Center of the Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences , University of Turin , Turin , Italy.
    (3c) SCU Nephrology and Dialysis, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences , University of Turin , Turin , Italy.

    Expert Review of Clinical Immunology 17 de OCTUBRE de 2018

  • Caracterización de la enfermedad por reflujo faringolaríngeo en pacientes de edad avanzada y ancianos

    Cervera-Paz FJ (1), Jordano-Cabrera M (2).

    (1) Departamento de Otorrinolaringología, Clínica Universidad de Navarra, Pamplona, España. Electronic address: jcervera@unav.es.
    (2) Centro de Salud Villafranca, Hospital Reina Sofía, Córdoba, España.

    Acta Otorrinolaringologica Española 07 de AGOSTO de 2018

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra